嗅球刺激减轻了阿尔茨海默氏症类疾病的进展
Morteza Salimi1, Milad Nazari2,3, Payam Shahsavar1
1Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
CNS neuroscience & therapeutics
|October 15, 2024
概括
在老鼠中,嗅球 (OB) 的电刺激改善了工作记忆,并减少了阿尔茨海默氏症 (AD) 病理. 这种微创方法通过调节大脑网络,为AD提供了一种新的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 生物医学工程 生物医学工程
背景情况:
- 阿尔茨海默病 (AD) 构成一个重大挑战,深度大脑刺激 (DBS) 显示出潜力,但受到侵入性的限制.
- 嗅觉灯泡 (OB),在阿尔茨海默病早期受到影响,并与记忆中心连接,是一个有希望的,可访问的干预目标.
- 恢复记忆电路中的神经活动对于缓解AD进展至关重要.
研究的目的:
- 为了研究嗅觉球泡电刺激对工作记忆在阿米洛伊德β (Aβ) 鼠模型的AD的影响.
- 评估关键大脑区域的病理和电生理变化,包括OB,中间前额叶皮质,海马体和脑内皮质.
主要方法:
- 模拟阿尔茨海默氏症类疾病的雄性Wistar大鼠每天接受1小时的双边OB电刺激,持续18天.
- 在刺激后进行了组织学,行为和局部现场潜力分析.
- 电极植入针对特定的大脑区域进行刺激和记录.
主要成果:
- 嗅球刺激有效抵消了粉样β斑块的积累.
- 与AD相关的工作记忆障碍被OB刺激预防.
- 在记忆任务期间,在刺激的区域观察到跨频段的增强功率和马频段的功能连接.
结论:
- 嗅觉通路刺激显示出在阿尔茨海默病治疗中调节深度记忆网络的潜力.
- 嗅觉通路通过鼻腔的可访问性支持开发最少侵入性的治疗策略.
- 这项临床前研究为针对嗅觉系统的AD提供了新的,不那么侵入性的干预措施的基础.
相关概念视频
Alzheimer's Disease: Treatment
166
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
166
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449


